跳转至内容
Merck
CN

P2191

聚（D,L-丙交酯-co-乙交酯）

lactide:glycolide (50:50), mol wt 30,000-60,000

别名:

LACTEL® B6010-2, PLGA

登录 查看组织和合同定价。

选择尺寸

关于此项目

线性分子式:
[C3H4O2]x[C2H2O2]y
UNSPSC Code:
12352211
PubChem Substance ID:
24898286
NACRES:
NA.25
MDL number:
MFCD00131930

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

聚（D,L-丙交酯-co-乙交酯）, lactide:glycolide (50:50), mol wt 30,000-60,000

InChI key

XBBVURRQGJPTHH-UHFFFAOYSA-N

SMILES string

OCC(O)=O.CC(O)C(O)=O

feed ratio

lactide:glycolide (50:50)

mol wt

30,000-60,000

storage temp.

−20°C

Quality Level

100

正在寻找类似产品? 访问 产品对比指南

Application

聚（D，L-丙交酯-共-乙交酯）已经用于在凝胶中提高和维持乳酸盐单体水平，其浓度与皮肤伤口有关。

Features and Benefits

控释生物活性剂、缝线和可生物吸收植入器件。

General description

聚（D，L-丙交酯-共-乙交酯）是一种可生物降解的生物相容性聚合物，可用于药物输送。它可用于治疗类风湿性关节炎、溃疡性结肠炎、克罗恩病、炎性肺病、以及眼部炎性疾病。聚（D，L-丙交酯-共-乙交酯）可作为潜在的癌症治疗靶标起作用。

Physical form

具有生物相容性且可生物降解的聚合物。

Legal Information

Lactel is a registered trademark of Evonik Corp

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCZ3738
0000484116
0000484117
0000484117
0000484116

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  5. Product P2191, Poly(D,L-lactide-co-glycolide), is a compound that is useful as a time-release agent in delivery systems such as herbicides, pesticides, and drugs.  What is the rate of degradation?

    The higher the lactic acid to glycolic acid ratio, the slower is the degradation rate of the polymer.  Molecular weight of the polymer is a contributing factor to the degradation; the lower the molecular weight, the faster the degradation rate of the polymer.  

  6. What is the glass transition temperature of Product P2191, Poly(D,L-lactide-co-glycolide)?

    The glass transition is 45-50°C; the melting point is amorphous.

  7. What is the viscosity of Product P2191, Poly(D,L-lactide-co-glycolide)?

    The viscosity of this product is lot-specific and can be found in the Certificate of Analysis.

  8. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

PLGA-based nanoparticles: an overview of biomedical applications
Danhier F, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society, 161(2), 505-522 (2012)
Characterization of biodegradable poly (D, L-lactide-co-glycolide) polymers and microspheres
Hausberger AG and DeLuca PP
Journal of Pharmaceutical and Biomedical Analysis, 13(6), 747-760 (1995)
Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms
Hunt TK, et al.
Antioxidants & Redox Signaling, 9(8), 1115-1124 (2007)
Ahmed A Abd-Rabou et al.
Biological trace element research, 193(2), 377-389 (2019-05-09)
Colon cancer in men and breast cancer in women are regarded as major health burdens, accounting for majority of cancer diagnoses globally. Doxorubicin (DOX) resistance in breast and colon cancers represents the main reason of unsuccessful therapy. The rationale of
Habibun Nabi et al.
Parasitology research, 116(1), 359-370 (2016-10-28)
Toxoplasmosis is one of the most common zoonotic protozoal diseases. Recent advances in biotechnology have produced recombinant protein, which are immunogenic, and progress in nano-pharmaceutics has generated encapsulated protein in nanospheres, which are suitable for vaccine delivery. DNA was extracted
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持